Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow WAT
Waters Corporation 10-Q filed Aug 11, 2026
Red flags
-
Share dilution
Shares outstanding rose 65.1% in a year, to 98.2 million
-
Receivables outpacing revenue
Receivables grew 172.2% while revenue grew 113.4% year over year
What changed
Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 4, 2025: 44 added · 39 removed · 28 modified; 4 with only figures updated
111 more changes in this Item, word by word, in Powerpack.
Powerpack